willdate

180 POSTS 0 COMMENTS

Low rate of arrhythmia in COVID-19 patients undergoing short-term hydroxychloroquine treatment

Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 who are risk assessed prior to receiving the drug. That...

First patients enrolled in study of LINQ ICM to detect heart...

Medtronic has announced the first enrolments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ insertable cardiac monitor (ICM)...

VivaLNK wearable ECG to be used in AF biomarkers study

VivaLNK has announced that the University of California, San Francisco (UCSF) (San Francisco, USA), will be utilising its continuous wearable electrocardiogram (ECG) sensor for...

Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices

Medtronic has received Breakthrough Device Designation status from the US Food and Drug Administration (FDA) for the Tyrx absorbable antibacterial driveline wrap, which is...

Boston Scientific to invest in pulsed field ablation device developer

Boston Scientific has signed an investment agreement with an exclusive option to acquire Farapulse, a privately-held company developing a pulsed field ablation (PFA) system...

US FDA approval for second generation AcQMap system

Acutus Medical has announces US Food and Drug Administration (FDA) 510(k) clearance of the second-generation AcQMap 3D imaging and mapping catheter which builds on...

Redesigning pathways to incorporate innovative technologies into primary care

Yassir Javaid (Northampton, UK) discusses the use of cloud-based technologies and machine learning to improve the treatment and detection of arrhythmias. What potential is there...

Heart Rhythm Congress gears up for first digital-only event

Details of the digital format for the Arrhythmia Alliance’s Heart Rhythm Congress 2020 (27–30 September) have been released, with the event to be hosted...

Medtronic’s TYRX envelope found to be cost effective for patients at...

Medtronic has announced new data from the WRAP-IT study, showing the TYRX absorbable antibacterial envelope (TYRX Envelope) is cost effective for patients at increased...

CoreMap completes US$10.5 million financing round

CoreMap has announced the completion of a US$10.5 million Series A financing round led by Qure Ventures. The round included existing investors such as...

Air pollution exposure multiplies risk of stroke in AF patients

Sufferers of atrial fibrillation (AF) who are exposed to greater levels of pollution have a 1.2-fold higher risk of stroke than their peers who...

VitalConnect begins TELESTAR-TAVR remote monitoring study

VitalConnect has announced the commencement of the TELESTAR-TAVR clinical study—Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients)—monitoring patients undergoing...

AHA calls for awareness of medication-induced arrhythmias

Healthcare professionals should become more familiar with medications that cause arrhythmias, according to a new scientific statement from the American Heart Association (AHA), published...

Stereotaxis robotic navigation systems installed in Phoenix and Helsinki

Stereotaxis has completed installations of the world’s first Genesis Robotic Magnetic Navigation (RMN) systems to treat heart rhythm disorders at Helsinki University Hospital in...

Arrhythmia Alliance launches online event for heart rhythm patients

Arrhythmia Alliance and its sister charities will launch the first virtual Patients Day on 27 September, with thousands of heart rhythm patients and healthcare...

Fitbit receives US and European approvals for ECG app to identify...

Fitbit has received 510(k) clearance from the US Food and Drug Administration (FDA), as well as Conformité Européenne (CE) marking in the European Union,...

Acutus announces pre-clinical results of a novel diagnostic workflow using its...

Acutus Medical has announced pre-clinical experimental results of a novel diagnostic and therapeutic workflow utilising the AcQMap system along with tissue-selective, non-thermal pulse field...

iRhythm wins AI award funding to trial Zio at NHS sites

iRhythm Technologies collaboration
iRhythm Technologies has been named a winner of the UK government’s Artificial Intelligence (AI) in Health and Care Award. The announcement was made by...

ACC announces revised dates for ACC.21

The American College of Cardiology (ACC) has announced that its 70th Annual Scientific Session, ACC.21 taking place in Atlanta, USA, will be held across...

Philips launches latest version of its Azurion imaging platform

Royal Philips has announced the next-generation of its Azurion image-guided therapy platform, designed to improve the quality and efficiency of interventional procedures. The Azurion...

ESC 2020 Congress: IMPACT-AFib finds no statistical difference in anticoagulant usage

A study investigating an educational intervention aimed at increasing the use of oral anticoagulants for stroke prevention among atrial fibrillation (AF) patients, found that...

Cardiologs and MicroPort CRM partner to offer AI-based ECG system in...

Cardiologs has announced an exclusive distribution agreement in France with MicroPort CRM, for the reselling of its cloud analysis solution for Holter electrocardiograms (ECGs)....

ESC 2020 Congress: Digoxin found to be favourable in rate control...

Digoxin should be considered as a first-line approach for rate control in patients with permanent atrial fibrillation (AF). This was the conclusion of the...

ESC 2020 Congress: AF associated with long-term mortality in primary PCI...

Atrial fibrillation (AF) is associated with long-term mortality in patients undergoing primary percutaneous coronary intervention (PCI), irrespective of left ventricular (LV) function, a study...

ESC 2020 Congress: Daiichi Sankyo announces results from ETNA-AF studies

Cardiac Rhythm news for specialists
Daiichi Sankyo Europe has announced one-year results of four sub-analyses from the European and global ETNA-AF (Edoxaban Treatment in routiNe clinical prActice in patients...

ESC Congress 2020: EAST-AFNET 4 finds early rhythm control improves AF...

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot...

ESC 2020 Congress: STOP AF First finds cryoballoon ablation safer than...

Cryoballoon catheter ablation as a first line treatment for paroxysmal atrial fibrillation (AF) was found to be safer and more effective than anti arrhythmic...

ESC Congress 2020: Guidelines push individualised approach to AF

Patients with arrhythmia should choose the treatment plan with their health professionals, according to European Society of Cardiology (ESC) guidelines published online today in...

Heart Rhythm Society publishes Cardiovascular Digital Health Journal

The Heart Rhythm Society has announced the publication of the inaugural issue of the Cardiovascular Digital Health Journal. The new journal focuses on the...

Biosense Webster launches latest generation of Carto heart mapping system

Johnson & Johnson Medical Devices Companies has today announced the launch of Biosense Webster’s Carto 3 system version 7 and the Carto Prime mapping...

Philips announces new imaging enhancements for Kodex-EPD system

Royal Philips has announced new imaging and workflow enhancements for its Kodex-EPD cardiac imaging and mapping system. The system is used to treat patients...

ESC Congress 2020: Smoking cessation linked to reduced stroke risk in...

Research presented at the ESC Congress 2020 (Virtual, 29 August–1 September) suggests that, among atrial fibrillation (AF) patients, those who quit smoking were 30%...

Low rates of bleeding and mortality reported in one-year results of...

Daiichi Sankyo Europe has announced the publication of one-year follow-up results from the ongoing ETNA-AF-Europe (Edoxaban Treatment in routiNe clinical prActice for patients with...

Digital platform takes 2020 ESC Congress to a wider audience

Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking place from 29 August–1 September, the event’s scientific chair Marco Roffi (University Hospitals...

Using advanced imaging to tackle complex arrhythmias

J Peter Weiss (Heart Institute, Banner University of Arizona Medical Center, Phoenix, USA) outlines his experience of the AcQMap (Acutus Medical) 3D imaging and...

Biosense Webster receives CE mark approval for QDot Micro ablation catheter

Johnson & Johnson Medical Devices has today announced European CE mark approval of Biosense Webster’s QDot Micro radiofrequency (RF) ablation catheter. According to a press...

Atrial fibrillation deaths “declining”, study finds

A study by researchers from the Boston University School of Public Health (BUSPH, Boston, USA) shows a decline in deaths related to atrial fibrillation...

First procedures performed in the USA using Watchman FLX LAAC device

Physicians at the Texas Cardiac Arrhythmia Institute (TCAI) at St David's Medical Center in Austin and Los Robles Health System in Thousand Oaks, became...

Fitness linked to lower arrhythmia recurrence after AF ablation

Patients undergoing atrial fibrillation (AF) ablation, who are physically fit before the procedure, have a much higher chance of benefiting from the procedure and...

JAHA retracts paper calling for end to cardiology diversity programmes

The Journal of the American Heart Association (JAHA) has retracted a paper published in March 2020, which drew criticism due to its conclusions about race and the role of affirmative action within...

Conformal Medical secures funding to support CLAAS device trial

Conformal Medical, a medical device company focused on reducing stroke in patients with atrial fibrillation (AF), today announced it has secured US$85 million in...

Integrated cardiac ablation performed using remote telerobotic system

Stereotaxis and Acutus Medical have announced the first integrated cardiac ablation procedure using remote TeleRobotic support. Gery Tomassoni of Baptist Health, Lexington, USA treated...

Eko and AstraZeneca announce digital cardiovascular health partnership

Eko has announced a collaboration with AstraZeneca to accelerate the development of digital health tools for the earlier screening of cardiovascular diseases, including heart...

Abbott begins IDE study of TactiFlex device for paroxysmal AF

Abbott has announced first enrolments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation...

Adagio Medical reports pre-clinical success combining cryoablation catheter with pulsed field...

Adagio Medical, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced successful pre-clinical results demonstrating its existing cryoablation catheter is also capable...

Prompt diagnosis “vital” in effective AF management

Dhiraj Gupta, consultant cardiologist and electrophysiologist at Liverpool Heart and Chest Hospital, (Liverpool, UK) discusses the current burden of atrial fibrillation (AF) on healthcare...

Mobile phones and smartwatches pose little risk of CIED interference

The risk of electromagnetic interference to cardiovascular implantable electronic devices (CIEDs) from smartwatches and mobile phones is low—although close proximity between an iPhone 6...

American College of Cardiology to launch JACC: Asia

The American College of Cardiology (ACC) is expanding its JACC family of peer-reviewed journals to include JACC: Asia, which will publish original manuscripts focused...

Holographic display may improve physician accuracy during cardiac ablation

Details of the first-in-human use of an augmented reality holographic display to aid physician accuracy during cardiac ablation have been published in the Journal...

Caption Health gains FDA approval for updates to its cardiac AI...

Caption Health, a developer of medical artificial intelligence (AI) technology, has received US Food and Drug Administration (FDA) 510(k) clearance for an updated version...

Funding secured to further study of AI systems for cardiovascular health

Digital health and artificial intelligence (AI) company Eko has been awarded a US$2.7 million Small Business Innovation Research (SBIR) grant by the National Institutes...

Next-generation Watchman LAAC device gains US FDA approval

Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman FLX left atrial appendage closure (LAAC) device. The device is...

LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

LifeSignals Group has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for the LifeSignals ECG Remote Monitoring Patch platform. The...

Women taking beta blockers for hypertension may have higher risk of...

Women taking beta blockers for hypertension with no prior history of cardiovascular disease have a nearly 5% higher risk for heart failure than men...

AHA Scientific Sessions 2020 to be held virtually

The American Heart Association (AHA) has announced that its 2020 Scientific Sessions will be presented as a 100% virtual experience in light of the impact...

ACC publishes pathway on the management of bleeding in patients on...

The American College of Cardiology has published an expert consensus decision pathway (ECDP) on the management of bleeding in patients being treated with direct...

Continuous electrocardiogram monitoring post-stroke patients uncovers AF in 4.6% of patients

Screening patients in a primary care setting over one year after occurrence of a stroke using seven-day Holter monitoring uncovered atrial fibrillation (AF) in 4.6%...

Paper highlights use of robotic system for catheter ablation in COVID-19...

Stereotaxis has announced the publication of a paper in the European Heart Journal highlighting the benefits of using robotic technology for the management of...

Lower rate of post-ablation arrhythmia recurrence found in patients with shorter...

Patients with atrial fibrillation (AF) episodes limited to less than 24 continuous hours had a significantly lower incidence of arrhythmia recurrence following AF ablation...

Athena Poppas

Athena Poppas is chief of cardiology at the Alpert Medical School of Brown University (Providence, USA) and has recently begun her term as the...

AliveCor launches KardiaCare subscription service

AliveCor has announced the launch of KardiaCare, a digital health subscription service offering digital tools to monitor heart data, risk factors, identify symptom triggers,...

US and European approval for Medtronic’s LINQ II insertable cardiac monitor

Medtronic today announced that it has received US Food and Drug Administration (FDA) clearance and CE mark approval for its LINQ II insertable cardiac...

Abbott receives US FDA approval for Gallant ICD and CRT-D devices

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation...

€3.7m funding round completed for cardiac AI developer inHEART

inHEART, developer of a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a funding round of €3.7m led...

Carag Bioresorbable Septal Occluder approved for US IDE trial

US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been granted for the Carag Bioresorbable Septal Occluder (CBSO). The CE-marked CBSO is...

Kardium receives CE mark for its Globe Mapping and Ablation System

Kardium has received CE mark approval for its Globe Mapping and Ablation System for the treatment of atrial fibrillation (AF). “This is an important milestone...

PCR e-Course 2020: Roll-in trial finds high device success rate for...

Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high implant success rate and a low procedural complication rate in...

PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes versus...

Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, major bleeding and all-cause mortality, in atrial fibrillation (AF) patients with a high...

Tenfold risk of arrhythmias in intensive care COVID-19 patients

Patients with COVID-19 who were admitted to an intensive care unit were 10 times more likely than other hospitalised COVID-19 patients to suffer cardiac...

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart...

Royal Philips has announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted premarket...

Smartphone app can identify lung congestion in heart failure patients

Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing early intervention before their condition deteriorates, a study presented...

Medtronic’s Micra AV TPS receives CE mark

Medtronic has received CE mark for Micra AV Transcatheter Pacing System (TPS), the world’s smallest pacemaker with atrioventricular (AV) synchrony. Micra AV is indicated for...

First US patients treated using HeartLight X3 ablation system

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the first patients have been treated commercially with the recently-approved HeartLight X3 endoscopic ablation system in the USA. The cardiac...

Biotronik announces initial launch of its His-Bundle Pacing tools

Biotronik has announced its commitment to giving physicians additional tools to pace in the His-Bundle, coinciding with the launch of its His-Bundle Pacing (HBP)...

Occupation: Influencer

Jeffrey L Turner, Brian Zenger and Benjamin Steinberg (all University of Utah School of Medicine, Salt Lake City), write that social media has become...

Societies publish consensus statement on risk assessment in arrhythmias

Global cardiac health societies have collaborated on a consensus statement on the diagnosis of arrhythmias, designed to provide physicians with practical proposals to improve...

Optical mapping used to assess effect of hydroxychloroquine on heart rhythm

Researchers have used an optical mapping system to observe how the malaria drug hydroxychloroquine, which has been touted as a possible treatment for COVID-19,...

Adagio Medical receives CE mark for iCLAS ablation system

Adagio Medical has received CE mark approval for its ultra-low temperature intelligent Continuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF)...

Cardiologists plot “return to normal” as COVID-19 restrictions ease

As electrophysiologists worldwide begin the process of restarting elective procedures put on hold due to the COVID-19 pandemic, cardiology departments are braced for a...

Cardiac Rhythm News Issue 48 – May 2020

Highlights: Cardiologists discuss the "return to normal" as COVID-19 restrictions ease Late breaking trials from HRS 2020 Science including: PRAETORIAN, UNTOUCHED and PINNACLE FLX ...

Bardy Diagnostics receives CE mark for 14-day CAM patch

Bardy Diagnostics has received CE mark certification for the 14-day version of the Carnation Ambulatory Monitor (CAM) patch, the p-wave centric ambulatory cardiac patch...

Heart Rhythm Congress moves to virtual event for 2020

The 2020 edition of the Heart Rhythm Congress (HRC 2020), which had been scheduled to take place 27–30 September in Birmingham, UK, has been...

Lancet study finds no benefit in use of hydroxychloroquine for COVID-19

A study into the use of hydroxychloroquine or chloroquine, published in The Lancet, has failed to find a benefit in hospital-outcomes from the use...

Music triggers individualised cardiac response

Play the same piece of music to two people, and their hearts can respond very differently. That is the conclusion of a study presented...

Eko launches AI-powered telehealth platform for cardiac exams

Eko has announced the launch of Eko Telehealth, an artificial intelligence (AI)-powered telehealth platform for virtual cardiac and pulmonary monitoring. Being used by more...

Acutus Medical and Biotronik announce electrophysiology alliance

Acutus Medical and Biotronik have announced a new alliance to provide a comprehensive portfolio of electrophysiology, mapping, ablation and accessory products for catheter-based treatment...

AI-based ECG analysis reduces false positives in AF detection

Cardiologs, in partnership with the Valley Health System, has announced the results of a clinical study that found the Cardiologs AI-based ECG analysis solution...

Durablate catheter results demonstrate feasibility in VT ablation

Thermedical has announced that results from a first-in-human early feasibility study (EFS) using the Durablate catheter to treat ventricular tachycardia (VT) were presented in...

Philips gains FDA clearance for the use of its ultrasound portfolio...

Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market a wide range of...

The evolution of cardiac care in the wake of COVID-19

David E Albert, founder and chief medical officer of AliveCor, considers the impact of the COVID-19 pandemic on the  monitoring and of management of...

FDA approves update to cardiac imaging system to aid COVID-19 diagnostics

The US Food and Drug Administration (FDA) has expedited clearance of an update to software from Caption Health, a medical artificial intelligence (AI) company,...

US FDA approval granted for HeartLight X3 endoscopic ablation system

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the US Food and Drug Administration (FDA) has approved the next-generation HeartLight X3 endoscopic ablation system for the treatment of...

Medtronic receives US FDA approval for Cobalt and Crome implantable ICDs

Medtronic has received US Food and Drug Administration (FDA) approval for its Cobalt and Crome implantable cardioverter-defibrillators (ICD) and cardiac resynchronisation therapy-defibrillators (CRT-D). ICDs monitor...

CONVERGE IDE trial results presented at HRS 2020 Science

AtriCure has announced results from the CONVERGE IDE clinical trial, which showed an 18% difference in favour of the hybrid Convergent procedure as compared...

HRS 2020 Science: UNTOUCHED study finds improved inappropriate shock rate using...

Findings from the UNTOUCHED study, presented online in a late-breaking trial session at HRS 2020 Science, showed that patients receiving subcutaneous implantable cardioverter defibrillator...

Medtronic shares results of BlueSync and Micra TPS CED studies

Medtronic has announced results from late breaking clinical trials, presented online at HRS 2020 Science, evaluating the MyCareLink Heart mobile app and the Micra...

Contact force sensing catheters “safe and effective” in persistent AF ablation

Contact force (CF) sensing catheters have been shown to be safe and effective in persistent atrial fibrillation (AF) ablation, according to the findings of...

Boston Scientific announces positive PINNACLE FLX study results

Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left...

HRS 2020 Science: PRAETORIAN trial demonstrates non-inferiority of S-ICDS compared to...

Subcutaneous implantable cardioverter defibrillators (S-ICDs) are as protective as transvenous implantable cardioverter-defibrillators (ICDs) in the prevention of sudden cardiac death, but have a better...

Results of PULSED AF trial presented at HRS 2020 Science

Initial results of the PULSED AF trial, the first-in-human results for paroxysmal or persistent atrial fibrillation (AF) treated with pulsed field ablation (PFA) were...

Heart Rhythm Society launches white paper on AF centres of excellence

New ESC guidelines on SVTs
The Heart Rhythm Society (HRS) has released a white paper announcing the rationale and core components for Atrial Fibrillation (AF) centres of excellence (CoE),...

Fitbit to enrol patients in AF detection study

Fitbit has today launched the Fitbit Heart Study, its first large-scale, virtual study to validate the use of its wearable technology to identify episodes...

LifeSignals receives CE mark for the ECG Remote Monitoring Patch

LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a disposable wireless remote monitoring system, intended for use by healthcare...

Sex and race disparities found in ICD interventions for cardiac patients

Results of a clinical trial show stark disparities in the use of life-saving implantable cardioverter defibrillator (ICD) interventions based on sex and race, suggesting...

VitalConnect granted Emergency Use Authorisation for cardiac monitoring in COVID-19 patients

VitalConnect has been granted Emergency Use Authorisation (EUA) status by the US Food and Drug Administration (FDA) as part of the response to the...

Study points to potential treatment for long QT syndrome

A study published in the Journal of the American College of Cardiology (JACC) provides the first direct evidence that KCNQ1 antibodies are able to...

Same-day discharge “feasible for majority of AF ablation patients”

Same-day discharge after atrial fibrillation (AF) ablation is feasible for the majority of patients when a standardised protocol is used, findings of a multicentre cohort study, published in the Journal of the American...

iRhythm offers home enrolment of Zio monitoring devices

iRhythm Technologies collaboration
iRhythm Technologies has announced a virtual platform to support patients and clinicians in the wake of COVID-19 by offering home enrolment for the company’s...

Coala Heart Monitor expands capabilities for monitoring COVID-19 patients

Coala Life has announced the expansion of capabilities to help monitor patients from home using the Coala Heart Monitor. This expansion is a result...

iRhythm makes board appointment

iRhythm Technologies has announced the appointment of Renee Budig to its Board of Directors effective 23 April 2020. Budig was appointed as a Class...

FDA advises close screening of COVID-19 patients receiving hydroxychloroquine

The US Food and Drug Administration (FDA) has issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, including serious and...

Mobile telemetry can aid QTc monitoring of COVID-19 patients

The use of mobile cardiac outpatient telemetry (MCOT) can help monitor COVID-19 patients taking hydroxychloroquine and azithromycin, while reducing potential exposure to the virus...

Heart Rhythm Society provides further advice for using hydroxychloroquine to treat...

The Heart Rhythm Society (HRS) COVID-19 Rapid Response Task Force has updated its guidance on QTc monitoring in COVID-19 patients. In the revised guidance,...

EU-funded project to assess AF screening algorithm

The European Society of Cardiology (ESC) is participating in two large-scale EU-funded projects to detect heart rhythm disorders and prevent sudden cardiac death. The first...

AI study launched to monitor cardiac safety of COVID-19 patients receiving...

  Cardiologs has announced the launch of a clinical study using the company’s artificial intelligence (AI) solution to remotely monitor the cardiac safety of COVID-19...

Cardiac Insight launches Heart@Home ECG test kit

Cardiac Insight has announced the launch of the Heart@Home electrocardiogram (ECG) test kit to address new telehealth demands placed on cardiology practices by the...

Vivek Reddy joins DiNovA Medtech as chief medical advisor

DiNovA Medtech has announced that Vivek Reddy will join the company as chief medical advisor and co-founder of portfolio company Nuomao Medtech to lead...

Carnation Ambulatory Monitor patch used to detect arrhythmias in COVID-19 patients

Bardy Diagnostics has announced that its Carnation Ambulatory Monitor (CAM) Patch has been chosen for use in protocols to measure QT Segments in COVID-19...

US heart societies express concern over using hydroxychloroquine and azithromycin for...

Presidents of leading cardiac organisations, including the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS), have...

Webinar: Cardiovascular specialists detail COVID-19 strategies

Cardiovascular specialists from across the globe shared current knowledge and key experience of managing COVID-19 patients as part of a webinar organised by the...

AHA issues oxygenation and ventilation guidance for healthcare providers

The American Heart Association (AHA), in conjunction with the American Association for Respiratory Care (AARC) and American Society of Anesthesiologists (ASA) is offering guidance...

Heart Failure 2020 in Barcelona cancelled

The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has announced that Heart Failure 2020 & the World Congress on Acute...

Athena Poppas begins ACC presidency

Athena Poppas (Providence, USA) is the new president of the American College of Cardiology (ACC). Her term officially began at the close of the...

HRS 2020 in San Diego cancelled due to COVID-19 concerns

Cardiac Rhythm news for specialists
Due to COVID-19 concerns and travel restrictions, the 2020 Heart Rhythm Scientific Sessions (HRS 2020) will not take place in San Diego, USA, on...

Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy

Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardiology/World Congress of Cardiology’s virtual scientific sessions (ACC.20/WCC Virtual) suggest that...

Virtual ACC: LivaNova highlights Vitaria data

Data on the use of LivaNova’s implantable neuromodulation technology, Vitaria, for heart failure patients has been shared at the American College of Cardiology/World Congress...

Virtual ACC: Ethanol infusion in vein of Marshall improves catheter ablation outcomes 

The infusion of ethanol via the vein of Marshall (VOM), coupled with catheter ablation, leads to improved outcomes for patients with persistent atrial ablation, according to the findings of a study presented by...

AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

The American Heart Association (AHA) has committed US$2.5 million to research efforts to better understand the novel coronavirus, COVID-19, and its interaction with the...

Funding round for developer of wrist-mounted blood pressure monitor

Aktiia, a Swiss-US start-up that has developed an optical blood pressure monitor at the wrist, has raised an additional CHF 6 million in funding...

Study recommends “widespread adoption” of CVC for CIED implantation

Cephalic vein cutdown (CVC) and axillary vein access (AVA) are both effective approaches for cardiac implantable electronic device (CIED) lead implantation, and could avoid...

Stereotaxis receives FDA clearance for Genesis Robotic Magnetic Navigation system

Stereotaxis has received US Food and Drug Administration (FDA) 510(k) clearance for the Genesis Robotic Magnetic Navigation (RMN) system for the robotic navigation of...

Focus on the Zio Patch wearable sensor in diagnosis of cardiac...

James Teo was the chief investigator in the EPACS clinical trial, testing the performance of the Zio Patch (iRhthym Technologies) wearable biosensor. He outlines...

EHRA 2020 to feature late-breaking arrhythmia studies

Twenty late-breaking trials, including major clinical studies on the treatment of atrial fibrillation (AF) are among the research to be presented at the annual...

Kalyanam Shivkumar named as editor-in-chief of JACC: Clinical Electrophysiology

Kalyanam Shivkumar has been named the next editor-in-chief of the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology. Shivkumar is a physician scientist...

Wearable sensor analytics platform predicts worsening heart failure prior to hospitalisation

Wearing an adhesive patch sensor that streams data to an analytical platform can accurately predict worsening heart failure (HF) and the need for hospitalisation...

Append Medical shares clinical proof-of-concept results for internal sealing of LAA

Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device to minimise stroke risk in atrial fibrillation (AF) patients, and...

Abbott receives CE mark approval for Gallant ICD and CRT-D devices

Abbott has announced that it has received CE mark approval for the Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices. The...

One in three patients treated in line with ICD guidelines

Decline in defibrillation testing during ICD implantation
A study of patients undergoing implantable cardioverter defibrillator (ICD) therapy across three centres, found that only one in three were treated in concordance with...

VitalConnect adds arrhythmia detection to its remote monitoring software

VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring portfolio. In partnership with CorVitals, VitalConnect now offers physicians the ability to...

ACC partners with AED device company for cardiac arrest alliance

The American College of Cardiology (ACC) and automated external defibrillator (AED) technology start-up HeartHero have formed an alliance aimed at making a “significant impact”...

AI-guided cardiac imaging system given FDA authorisation

The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acquisition of cardiac ultrasound, or echocardiography, images. The...

CardioFocus submits HeartLight X3 PMA application to FDA

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...

Value of augmented reality goes well beyond holograms in the electrophysiology...

 Jennifer Silva (St Louis, USA) talks to BLearning Cardio at SIR 2019 (Society of Interventional Radiology; 23–28 March; Austin, USA) about why physicians should...

Medtronic receives CE Mark for Cobalt and Crome implantable ICDs

Medtronic has received CE Mark for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy-defibrillators (CRT-D). ICDs monitor heart rhythms...

Eko receives FDA clearance for AF and heart murmur algorithms

Eko has announced that the US Food and Drug Administration (FDA) has cleared a suite of algorithms that, when combined with Eko’s digital stethoscopes,...

AF Symposium 2020: Acutus Medical live streams case using AcQMap System

Acutus Medical offered a demonstration of its AcQMap advanced cardiac imaging and mapping system at AF Symposium (23–25 January, Washington, DC, USA) with a live-stream...

Medtronic gains FDA approval for PulseSelect trial

Medtronic has received approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the...

BardyDx announces commercial launch of the 14-day CAM Patch

Bardy Diagnostics (BardyDx) has today announced the commercial launch of the 14-Day version of the Carnation Ambulatory Monitor (CAM), the P-wave centric ambulatory cardiac...

Biotronik announces Japanese launch of injectable cardiac monitor

biomonitor
Biotronik has announced the market release of its injectable cardiac monitor (ICM), BioMonitor III in Japan. The device is designed to help patients with...

Hypocapnia could aid ablation of cardiac arrhythmias

A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as a treatment...

AI and its growing role in arrhythmia

Malcom Finlay (Bart's Health Centre, London, UK) reviews the growing role of artificial intelligence (AI) in diagnosing arrhythmias.  Johnny, a 72-year-old film producer, is meeting...

Medtronic receives FDA approval for Micra AV

Medtronic has announced that it has received US Food and Drug Administration (FDA) approval of Micra AV, the world’s smallest pacemaker with atrioventricular (AV)...

CardioFocus appoints Burke T Barrett as chief executive

CardioFocus, has announced that the company’s board of directors has promoted Burke T Barrett to the position of chief executive officer (CEO), effective January...

First patient enrolled in PREDICT-LAA clinical trial

FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The trial is led by Righshospitalet (Copenhagen, Denmark) and aims...

Cardiac Rhythm News Issue 47 – January 2020

Cardiac Rhythm News Issue 47
Highlights: WRAP-IT shows significant mortality risk with CIED infection, and reduced quality of life Sequential approach using STAR mapping system identifies key early sites...

Leading electrophysiologists identify four key studies that will shape arrhythmia treatment...

Leading electrophysiologists have pinpointed four clinical studies due to report findings in 2020—AMULET IDE, aMAZE IDE, PULSED AF and CEASE AF—that they expect to...

Persistent atrial fibrillation—seeking the sources of the cardiac electrical field

Andrew Grace charts the evolution of non-contact mapping culminating in the current AcQMap system—the technology has advanced understanding of persistent atrial fibrillation (AF), providing...

Eric N Prystowsky

Eric Prystowsky
Eric N Prystowsky (director of the Cardiac Arrhythmia Service at St Vincent Hospital, Indianapolis, and a consulting professor of medicine at Duke University Medical...

NICE recommends use of Reveal LINQ implantable cardiac monitor

The UK National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of the Reveal LINQ (Medtronic) implantable cardiac...

Ed Vertatschitsch joins Bardy Diagnostics as chief operating officer

Bardy Diagnostics (BardyDx) has announced today the appointment of Ed Vertatschitsch as chief operating officer. Effective 2 January 2020, the appointment will see Vertatschitsch...

ACC makes senior staff appointments

American College of Cardiology makes senior staff appointments
The American College of Cardiology (ACC) has announced several promotions and structural changes within its senior staff. The College said that the staff changes...

Stryker launches voluntary field action for LIFEPAK 15

Stryker
Stryker has launched a voluntary field action on specific units of the LIFEPAK 15 monitor and defibrillator. In an announcement issued by the company on...

AtriCure announces completion of enrolment for aMAZE clinical trial

  AtriCure has announced the successful completion of patient enrolment in the aMAZE clinical trial. In addition, the company announced that it has received approval...

FDA grants Breakthrough designation for ECG-based algorithm

ECG based algorithm
The US Food and Drug Administration has granted Breakthrough Device designation to the digital health and artificial intelligence (AI) company Eko for an echocardiogram...

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

European Trial Data
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...

First patients treated in robotic arrhythmia care programme at Overland Park...

Dhanunjaya Lakkireddy performs the first robotic cardiac ablation procedure at OPRMC
Stereotaxis announced today that HCA Midwest Health has launched a new robotic arrhythmia care programme based at Overland Park Regional Medical Center (OPRMC). Installation...

FDA panel votes against approval of AF drug Brinavess

Cardiac Rhythm news for specialists
The US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted not to recommend approval for the anti-arrhythmic drug...

Impulse Dynamics secures funding to commercialise Optimizer Smart

Impulse Dynamics has announced the completion of a US$80.25 million Series D financing round with new investors. Proceeds will be used primarily to facilitate...

Tackling focal VT may improve catheter ablation in structural heart disease

Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published...

VivaLnk’s multi-vital wearable sensor and software development kit receive CE mark

VivaLnk has announced it has received the class IIa medical device CE mark for its multi-vital medical wearable sensor and software development kit (SDK). The...

PADIT score predicts CIED infection risk

Five independent predictors of cardiac implantable electronic device (CIED) infection have been identified which could be used to aid physicians and patients in decision-making...

Pedro Brugada

With his brothers Josep and Ramon, Pedro Brugada discovered the syndrome that bears their name. He reflects on his career highlights with Cardiac Rhythm...

AHA 2019: Correvio announces new data from SPECTRUM Brinavess study

Cardiac Rhythm news for specialists
Correvio announced the presentation of new data from the SPECTRUM study evaluating Brinavess (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion of...

Cardiac Rhythm News Issue 46 – October 2019

Highlights: ESC guidelines on supraventricular tachycardias underline the pivotal role of catheter ablation therapy Study suggests increased use of DOACs in AF leads to...

Left atrial appendage closure associated with a decreased stroke risk in...

Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...

First patients treated using integrated navigation technology from Stereotaxis and ADAS...

Stereotaxis and ADAS 3D Medical have announced that the first patients have been treated with the integration of ADAS 3D’s advanced preoperative substrate mapping...

CardioFocus treats first patients with HeartLight endoscopic ablation system in France

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...

Cardiva Medical announces publication of data from AMBULATE pivotal study

Cardiva Medical has said that results from the AMBULATE pivotal study demonstrate the safety and efficacy of its VASCADE MVP venous vascular closure system...

Bardy Diagnostics wins digital health pitch session at ESC Congress

Bardy Diagnostics announced that it was selected as winner of the ‘Remote Monitoring in Arrhythmias’ Technology and Innovation Pitch Session held as part of...

Low bleeding and cardiovascular events in elderly NVAF patients using edoxaban,...

Cardiac Rhythm news for specialists
Daiichi Sankyo has announced one-year follow-up results from an analysis of 12,574 European non-valvular atrial fibrillation (NVAF) patients, mostly elderly, treated with edoxaban (Lixiana)....